...
首页> 外文期刊>Journal of genetics >Genetic and expression changes in TNF-?± as a risk factor for rheumatoid arthritis pathogenesis in northeast India
【24h】

Genetic and expression changes in TNF-?± as a risk factor for rheumatoid arthritis pathogenesis in northeast India

机译:遗传和表达在TNF-?±作为印度东北部的类风湿性关节炎发病机制的危险因素

获取原文
           

摘要

Antitumour necrosis factor-alpha (TNF-?±) therapy is used as a clinical intervention for rheumatoid arthritis (RA) but differences exist in response to the treatment which makes the candidature of the screening of TNF-?± alteration(s) at genetic and expression levels an important agenda prior to treatment. This study aims to determine the associative role of TNF-?± a??308G/A polymorphism and differential expression of TNF-?± in the pathogenesis of RA. A casea??control study where a total of 126 RA patients were enrolled based on ACR-EULAR (2010) criteria, along with 160 community matched age and sex controls over a period of three years. The differential expression level of TNF-?± mRNA and protein level was studied and TNF-?± a??308G/A polymorphism was screened by T-ARMS PCR assay. All statistical analysis was performed using SPSS software. mRNA expression level of TNF-?± was upregulated in RA cases (avg. 15.85 ?± 9.52 fold) compared to control. TNF-?± protein level was found to be higher in RA cases (28.62?±7.17 pg/mL) compared to control (23.14?±6.91 pg/mL). TNF-?± a??308 variant GA genotype was higher in RA (46.03%) than in control (25%). The presence of TNF-?± a??308 variant A allele was associated with increased risk of RA susceptibility (odds ratio (OR) = 2.559 at 95% confidence interval (CI), P 0.001) but not severity (OR = 1.617 at 95% CI, P = 0.571). The presence of a??308 variant genotype was associated with a higher TNF-?± mRNA and protein expression. The presence of TNF-?± a??308A allele is associated with increased risk of RA susceptibility and differential TNF-?± expression, and has prognostic significance. Association of higher TNF-?± pro-inflammatory cytokine levels with northeast Indian patients makes them suitable subjects for anti-TNF-?± therapy.
机译:抗肿瘤坏死因子-α(TNF-α±)治疗用作类风湿性关节炎(RA)的临床干预,但响应于治疗的差异存在于遗传术中筛选TNF-α±改变的候选和表达水平治疗前的重要议程。本研究旨在确定TNF-α的关联作用308g / a ?? 308g / a多态性和TNF-β±差异在Ra的发病机制中的差异表达。一个卡西亚的对照研究,基于ACR-euary(2010)标准,共有126名RA患者,以及160个社区匹配年龄和性别控制,在三年内。研究了TNF-α±mRNA和蛋白质水平的差异表达水平,并通过T臂PCR测定筛选308g /ααααααααααααβ。使用SPSS软件进行所有统计分析。与对照相比,在RA病例(AVG。15.85±9.52倍)中上调TNF-α±mRNA表达水平。与对照(23.14±6.91pg / ml)相比,RNF-α蛋白水平在RA病例(28.62〜±7.17 pg / ml)中较高。 TNF-?±A ?? 308变体GA基因型在Ra(46.03%)中高于对照(25%)。 TNF-αααα的存在308变体与Ra易感性的风险增加有关(在95%置信区间(CI),P <0.001)但不严重程度(或= 1.617)的增加有关(OR)= 2.559的风险增加在95%CI,P = 0.571)。存在308个变体基因型的存在与较高的TNF-α±mRNA和蛋白质表达有关。 TNF-α±a ?? 308a等位基因的存在与RA易感性和差异TNF-α±表达的风险增加有关,并且具有预后意义。与东北印度患者的较高TNF-α-炎症细胞因子水平的关联使其适用于抗TNF-α±疗法的受试者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号